Congress Tackles Drug Prices: Much Bipartisan Support; and Recent Trends in Drug Costs Here and What Other Countries Pay

Finally it looks like Congress might just re-visit Medicare Part D and let Medicare negotiate rates with drug companies.   See charts below: http://www.statnews.com/2015/12/01/stat-harvard-drug-prices-poll/  The VA and Medicaid can negotiate rates.

Senate Special Committee on Aging holds drug costs hearing December 9th.  Follow the link below to drug price trends. Scroll down to see what other countries charge.  One chart shows a spike in drug prices in the 1990s.  That was when drug companies were allowed to start direct to consumer advertising.

http://www.healthsystemtracker.org/chart-collection/what-are-the-recent-and-forecasted-trends-in-prescription-drug-spending/?utm_campaign=KFF%3A+The+Latest&utm_source=hs_email&utm_medium=email&utm_content=24440105&_hsenc=p2ANqtz-9O62mlomhQ_hY-o6Uf9i87Wl1IUg4rcJbAdWsRK0XPuEqYBVc9tQ7kSHQm-qw0vsrXnbKsXja_V65UkQqYF2NKUvVX9A&_hsmi=24440105

So, once again. If you want to see lower drug costs, write to your Senators and Representative and tell them to let Medicare negotiate rates with drug companies. 

Kathleen O’Connor © December 9, 2015

 

About Kathleen

Kathleen O’Connor: 30+ year health care consumer advocate, non-profit executive and author. For more information about Kathleen, please see "About" on the main content bar above.
This entry was posted in aging, Economy, media, Medicare, pharmaceutical companies, policy and politics, politics, prescription drugs, technology and pharmaceutical costs and tagged , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *